Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 13.57M P/E - EPS this Y - Ern Qtrly Grth -
Income -57.21M Forward P/E -3.47 EPS next Y - 50D Avg Chg 3.00%
Sales 989k PEG - EPS past 5Y - 200D Avg Chg -5.00%
Dividend N/A Price/Book 0.12 EPS next 5Y 47.30% 52W High Chg -58.00%
Recommedations 5.00 Quick Ratio 7.43 Shares Outstanding 1.82M 52W Low Chg 20.00%
Insider Own 8.31% ROA -34.31% Shares Float 1.01M Beta -
Inst Own 44.03% ROE -68.60% Shares Shorted/Prior 12.26K/13.93K Price 7.57
Gross Margin - Profit Margin - Avg. Volume 15,076 Target Price -
Oper. Margin -19,338.36% Earnings Date May 9 Volume 2,929 Change 2.02%
About Talis Biomedical Corporation

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

TLIS Chatroom

User Image youspeaktome Posted - 5 days ago

$TLIS https://www.sec.gov/ix?doc=/Archives/edgar/data/0001584751/000095017024052949/tlis-20240429.htm Not sure what this new 8k means. I read it as Baker Brothers can't sell their common stock and convertible preferred until the S-3 is eligible again.

User Image youspeaktome Posted - 04/24/24

$TLIS In this for either a liquidation or a reverse merger. Tons of cash on the balance sheet and they laid off 90% of the employees so cash burn should be minimal going forward. Also Baker Brothers own all of the preferred and 1/3 of the common. Very low tradeable float. We should hear something soon it's been 5 months Good thread I found on twitter explaining the net asset value https://twitter.com/JanuaryFly/status/1773351855193538692

User Image DirkySploosh Posted - 1 month ago

$TLIS Following movement here again. Goes over $9 then has dipped around $7 a few different times this year. Will get back it under $7.

User Image valorallure Posted - 1 month ago

$TLIS This one is cheap. I like the value. Only issue I'm having is putting a value on possible lawsuit settlement. Company is being sued by IPO investors and trial date is set for February 2rth,2025. Curious if this will affect sale process.

User Image Car_key Posted - 03/14/24

$TLIS Anyone has any clue when we are getting our Money?

User Image ReactionAction Posted - 2 months ago

$TLIS Line around $8.50 $8.50 - $4.50 =$4.00 $8.50+$4.00= $12.50 minimum short term A lot of reaction around $8.50-$9.00 Volume gap between $9 and $18 Long term- From $18 to $150 another volume gap going back to 2021 If it plays out.

User Image ReactionAction Posted - 2 months ago

$TLIS such an under the radar name. Spread is too wide for day traders to play. Need liquidity. It’s still less than 900K float Baker bros and Greenlight owning more than 70% scare the pump and dump scammers away. I do not believe this has ever gone up/down more than 30% in a day which was when they announced strategic alternatives in November 2023. Will it be different with strategic moves going forward?

User Image ReactionAction Posted - 02/29/24

$TLIS Baker Bros average? $120/share with private financing prior to IPO Greenlight Capital average? $75/share bought in early 2022 TD Cowen advising independent board for strategic alternatives. Covid failure for Baker bros. Now they need to recover $300 million. Not a pocket change. Remember Baker has cash that need to put into work after $SGEN acquisition. PIPE financing probable with reverse merger

User Image DirkySploosh Posted - 02/29/24

$TLIS Tracking this stock. Want some biotech exposure, has a runway to pop above $12.

User Image Car_key Posted - 02/13/24

$TLIS Chart looks mesmerizing.

User Image ReactionAction Posted - 3 months ago

$TLIS

User Image ReactionAction Posted - 3 months ago

@Tandava $TLIS preferred shares liquidation preferences are literally $3.00. A lot of investors confused. Confirmed with IR.

User Image Tandava Posted - 3 months ago

@ReactionAction you should compare what those companies net cash are at the point of announcement because that's their currency to effect a deal and get a good price split on valuation with the newco.......fwiw $TLIS is in the top 5% of net cash positions and is not on the radar of a lot of deep value specialists because of the preferred share class complexity and how they worded their initial press release

User Image ReactionAction Posted - 3 months ago

@Car_key yes $TLIS fill the gap

User Image Car_key Posted - 3 months ago

$TLIS Looks like it is going to fill that Gap.

User Image ReactionAction Posted - 01/29/24

$TLIS $50+ it will get there Even with this market cap would be $210 million

User Image Car_key Posted - 01/29/24

$TLIS One of these days we will wake up to see +300% Gain

User Image Last10K Posted - 01/26/24

$TLIS just filed with the SEC a Event for Officers https://last10k.com/sec-filings/TLIS/0000950170-24-007975.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=TLIS

User Image ReactionAction Posted - 01/24/24

$TLIS love sign ❤️

User Image ReactionAction Posted - 01/24/24

$TLIS interesting $25/share in cash and very slow burn Baker $300 million paper loss. Strategic Alternatives possible $50+ (double the cash)

User Image Car_key Posted - 01/24/24

$TLIS Cash 88 mil. Debt 20mil. Book Value $44 per share. Insider holding over 8% Institution holding over 40%. Company reduced 90% work force and looking for alternatives. This is definitely Buy and Hold.

User Image ReactionAction Posted - 11/30/23

$TLIS Not much news and will hover but what happens when during pullback/correction? Gap still uneasy

User Image ReactionAction Posted - 11/20/23

Last one that’s 165% average increase $SYRE was 3 month search I am buying $TLIS

User Image ReactionAction Posted - 11/20/23

Recent reverse merge: $KRRO $10 to $20 and then $50 $LENZ $2 to $3.4 and then $2.37 $TALS $1 to $3 and then $2.77 $SYRE $4.5 to $20 and then $10 Private placement and confidence and obviously, good selection helps. $TLIS $4.5 to ?

User Image ReactionAction Posted - 11/20/23

Correction $AVRO 38% to 63% $2.38 in cash currently, traded $1.52 from $0.90 Revised average is 44% to 56% Implied $TLIS if consistent with other recent strategic alternatives: Current cash $25/share X 44% = $11 X 56% = $14 Currently at $7. More Intriguing

User Image ReactionAction Posted - 11/20/23

$TLIS comparing to other strategic alternatives, cash to market cap%. Before announcement and after announcement: $AVRO 19% to 32% $THRX 37% to 55% $ELYM 68% to 62% $GLTO 36% to 44% Avg. 40% to 48% $TLIS 18% to $28% What’s the discount factor outside of no interest and medical device co. / used to be Covid?

User Image ReactionAction Posted - 11/20/23

$TLIS Independent board seeking to buy or execute reverse merger: Randy Scott - founded: $INCY (EV $8.7 biotech) Genomic Health ($2.8buyout by $EXAS 2019 genomic) $NVTAQ (EV $1.4B genetics) Kim Popovits (Chairman and CEO Genomic Health 2012-2019 before acquisition) Matt Posard (Chairman of $DMTK) Heiner Dreismann (Former CEO of Roche Molecular Systems) Baker Bros, CEO, and co-Founder are not considered independent. Greenlight Capital David Einhorn owns 20% I believe. I believe this will see $15 to $30 in the near term. 28% cash to market cap. 90% cash burn reduction or from $15 million / q to $1.5 million. $88 million 9/30 cash bal, $10 million burn through 2024 = $78 million / 3.5 m = $22/share by end of 12/31/24 Intriguing and market not realizing. About 500,000 shares float based on my estimate.

User Image ReactionAction Posted - 11/17/23

$TLIS Drying up

User Image TickerDD_com Posted - 11/16/23

$TLIS Short Interest for the 2-Week Period ending on 31-Oct-2023 #TLIS #shortinterest #chinesestock https://www.youtube.com/watch?v=nfP4PKNy26g

User Image ReactionAction Posted - 11/16/23

$TLIS spread is at times 10%. Interest winding down.

Analyst Ratings
BTIG Sell Aug 16, 23